GSK Launches Late-Stage Trial for Groundbreaking mRNA Flu Vaccine, ETPharma
Bengaluru: GSK said on Tuesday it will advance its mRNA-based seasonal influenza vaccine candidate to a late-stage trial…
#EuropeSays #Britain #Europe #EU #GSK #GSKmRNAfluvaccine #haemagglutinin #immuneresponses #late-stagetrial #seasonalinfluenzavaccine
https://www.europesays.com/britain/115811/